Magnus Medical
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1350 Bayshore Hwy Ste 600, Burlingame, C...Phone Number
(415) 231-7407Website
www.magnusmed.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Magnus Medical
Magnus Medical, Inc., is a privately held medical device company driven to transform lives by restoring mental health. Magnus' first FDA-cleared product is the Magnus neuromodulation system delivering targeted SAINT treatment, providing a new form of individualized neurostimulation for adults who have failed to achieve satisfactory improvement from prior antidepressant medications. SAINT was developed at Stanford University and licensed exclusively to Magnus Medical in October 2021 for commercialization.Explore more
Magnus Medical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Magnus Medical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Magnus Medical is spiking on competitors!
Earning: See what the market has to say on Magnus Medical recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Magnus Medical
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Magnus Medical has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Magnus Medical, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Magnus Medical has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Magnus Medical launches new products
Click to see if Magnus Medical had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Magnus Medical
Compare insights from companies similar to Magnus Medical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Magnus Medical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Magnus Medical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Magnus Medical.
Magnus Medical financials insights
Gather financial insights about Magnus Medical, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$25M
Magnus Medical Tech Stack
A closer look at the technologies used by Magnus Medical
Most Recent Scoops
Promotion
Executive Move
Achal Achrol has recently been promoted from Chief Medical Officer to the role of Chief Executive Officer.
Executive Moves, Promotion
Open Position
Hiring Plans
Magnus Medical is hiring in Marketing for the first time in 12 months.
Hiring Plans
Hiring Plans
Magnus Medical has more open roles in Sales than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
Hiring Plans
Magnus Medical News & Media
Magnus Medical Highlights New Clinical Data on Groundbreaking SAINT Therapy at 2024 NYC Neuromodulation Conference
BURLINGAME, Calif.--(BUSINESS WIRE)-- #NYCN2024--Magnus Medical, Inc., a pioneering therapeutic neuromodulation company transforming the treatment of neuropsychiatric disorders, today announced promising new clinical data on SAINT® therapy at the 2024 NYC Neuromodulation Conference, Aug 1-3. The research will be presented in two posters demonstrating the long-lasting benefits of SAINT treatment and its potential for personalized continuation therapy in people with treatment-resistant depressionMagnus Medical Announces Commercial Launch of Groundbreaking SAINT Neuromodulation System
BURLINGAME, Calif.--(BUSINESS WIRE)-- #DepressionTreatment--Magnus Medical announces the commercial launch of its groundbreaking SAINT® neuromodulation system for the treatment of major depression.Magnus Medical Announces American Medical Association Issues New CPT Category III Codes for Targeted, Accelerated Intermittent Theta-Burst Stimulation
BURLINGAME, Calif.--(BUSINESS WIRE)-- #AMA--Magnus Medical, Inc., a medical device company and developer of brain stimulation technology for the treatment of neuropsychiatric disorders, today announced that the American Medical Association (AMA) has issued new Category III Current Procedural Terminology (CPT) codes for targeted, accelerated intermittent theta burst stimulation (iTBS) for depression, encompassing Magnus’ SAINT™ targeted treatment. The new codes will be published January 1, 2024,Magnus Medical Announces First Participants Treated in Study Using SAINT Neuromodulation System for Major Depression
BURLINGAME, Calif.--(BUSINESS WIRE)-- #DepressionTreatment--Magnus Medical, Inc., a medical device company and developer of brain stimulation technology for the treatment of neuropsychiatric disorders, today announced that the first participants have been treated in the Open Label Optimization (OLO) Clinical Trial evaluating the effectiveness of the Magnus Neuromodulation System with SAINT™ Technology for the treatment of Major Depressive Disorder (MDD). “We are very pleased to announce the star
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Magnus Medical
Sign Up For FreeTo access detailed company insights
Magnus Medical, Inc., is a privately held medical device company driven to transform lives by restoring mental health. Magnus' first FDA-cleared product is the Magnus neuromodulation system delivering targeted SAINT treatment, providing a new form of individualized neurostimulation for adults who have failed to achieve satisfactory improvement from... Read More
